Vaxart (NASDAQ:VXRT) Upgraded by BidaskClub to Buy

0
29

Vaxart stock has undergone multiple analysts rating changes in the recent past.  Vaxart Upgraded by BidaskClub on 6/30/2020. In a note to investors, the firm issued a new rating of Buy. The analysts previously had rating of Hold.

Shares of Vaxart traded down -$0.55 on Monday, reaching $7.49. 149022 shares of the stock traded hands, compared to its average volume of 17042903. Shares of Vaxart ended Monday on at $7.49. The firm’s 50 day moving average is $3.02 and its 200 day moving average is $1.39.Vaxart  has a 12 month low of $7.32 and a 12 month high of $14.30. While on yearly highs and lows, Vaxart’s today has traded high as $9.89 and has touched $7.32 on the downward trend. See More Analyst Rating at: RATING

Vaxart Earnings and What to expect: 

Vaxart last released its earnings results on May 12th, 2020. The biotechnology company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.04) by $0.02. The firm earned $2.90 million during the quarter, compared to analysts’ expectations of $2.80 million. Vaxart has generated ($0.86) earnings per share over the last year. Vaxart has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, August 13th, 2020 based off prior year’s report dates.

Earnings for Vaxart are expected to decrease in the coming year, from ($0.19) to ($0.34) per share. The P/E ratio of Vaxart is -8.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Vaxart is -8.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Vaxart has a P/B Ratio of 27.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Latest Insiders Trading and Volume : 

  • Insider Ownership Percentage: 36.70%
  • On 6/3/2020 Director Armistice Capital, Llc Sell 400,000 at average share price of $2.77 which equates to $1,108,000.00 in money value.
  • On 6/1/2020 Director Armistice Capital, Llc Sell 200,000 at average price of  $2.74 with total value of : Not Data Available
  • On 5/27/2020 Director Armistice Capital, Llc Sell 200,000 at average price of  $2.61 with total value of : $522,000.00

Analyst at BidaskClub are also talking about :

  • 6/30/2020 – Winmark was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating.
  • 6/30/2020 – VSE was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating.
  • 6/30/2020 – Verisign was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating.
  • 6/30/2020 – Verisk Analytics was upgraded by analysts at BidaskClub from a “buy” rating to a “strong-buy” rating.

Vaxart (NASDAQ:VXRT) Moving Average Technical Analysis

5 day Moving Average is $5.53 And 5 day price change is $4.82 (180.52%)  with average volume for 5 day average is 93,955,227. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $3.27 and 20 day price change is $4.71 (169.42%) and average 20 day moving volume is 26,341,432. 50 day moving average is $3.02  and 50 day price change is $5.50 ( 276.38%)  and with average volume for 50 days is : 16,457,465. 200 day moving average is $1.39  and 200 day price change is $6.87 (#ERROR!)  and with average volume for 200 days is : 8,056,299.

See More Analyst Rating at: RATING